Effect of Statins on Serum Prostate-specific Antigen Levels (Q42982919)

12 November 2017

Effect of Statins on Serum Prostate-specific Antigen Levels (English)

1 reference

12 November 2017

Bulent Akduman

1

1 reference

12 November 2017

Daniel J Tandberg

2

1 reference

12 November 2017

Colin I O'Donnell

3

1 reference

12 November 2017

Alexa Hughes

4

1 reference

12 November 2017

Mark A Moyad

5

1 reference

12 November 2017

E David Crawford

6

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 November 2010

1 reference

12 November 2017

1 reference

12 November 2017

76

1 reference

12 November 2017

5

1 reference

12 November 2017

1048-1051

1 reference

Statins and the risk of dementia

12 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.044

Oral simvastatin treatment in relapsing-remitting multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.044

Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.044

Statins and prostate cancer risk: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.044

In vitro mechanisms of lovastatin on lung cancer cell lines as a potential chemopreventive agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.044

Statins and the risk of colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.044

The effect of statins on serum prostate specific antigen levels in a cohort of airline pilots: a preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.044

The influence of statin medications on prostate-specific antigen levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.044

Cholesterol and prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.044

Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.044

The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.044

Inhibition of Hydroxymethylglutaryl-Coenzyme A Reductase Reduces Th1 Development and Promotes Th2 Development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.044

Statins have biphasic effects on angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.044

Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.044

Lovastatin inhibits Rho-regulated expression of E-selectin by TNFalpha and attenuates tumor cell adhesion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.044

Statin drugs and risk of advanced prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.044

Cholesterol-lowering drugs and prostate cancer risk: a population-based case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.044

The Risk of Cancer in Users of Statins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.044

Statin use and risk of prostate cancer in the California Men's Health Study cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.044

Statin use and risk of prostate cancer: results from a population-based epidemiologic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.044

Statins and cancer risk: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.044

Statins and cancer risk: a literature-based meta-analysis and meta-regression analysis of 35 randomized controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.044

Statin drugs, serum cholesterol, and prostate-specific antigen in the National Health and Nutrition Examination Survey 2001-2004.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.044

Prostate cancer and PSA among statin users in the Finnish prostate cancer screening trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.044

Do statins affect androgen levels in men? Results from the Boston area community health survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.044

10.1016/J.UROLOGY.2010.03.044

7 January 2021

Identifiers

DOI

1 reference

12 November 2017

1 reference